ClinicalTrialsFinder
RecruitingNCT07489911

Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)

A Prospective Non-Interventional Real-world Study Assessing the Effectiveness of Extrafine BDP/FF/G HS Single Inhaler Triple Therapy (SITT) on Symptom Scores in Asthma Patients After 6 Months Treatment

Sponsor

Chiesi Slovenija, d.o.o.

Enrollment

200 participants

Start Date

Nov 4, 2024

Study Type

OBSERVATIONAL

Conditions

AsthmaAsthma BronchialeAsthma Patients

Summary

The mainstay of asthma treatment are ICSs, mostly combined with LABA. In the past decade LAMA had been accepted as an add-on treatment for patients at GINA steps 4 and 5. Recently, RCTs proved the efficacy and safety of fixed triple combinations of moderate and high dose of ICS and LABA, LAMA in a very selected asthmatic population, resulting in the market authorisation of these products. However, there is a lack of evidence on the real-world effectiveness of these therapies, especially with regards to improvement in symptom scores and adherence.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called BDP/FF/G (beclometasone dipropionate/formoterol fumarate dihydrate/glycopyrronium) 172/5/9 μg for people with asthma, asthma bronchiale, and other related conditions. The study is currently recruiting participants at 18 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBDP/FF/G (beclometasone dipropionate/formoterol fumarate dihydrate/glycopyrronium) 172/5/9 μg

extrafine SITT

Locations(18)

AMBULANTA ARIA, specialistična ambulanta za alergijske in pljučne bolezni, d.o.o.

Celje, Slovenia

Dr. ŠEGOTA - PULMOLOG, specialistične zdravstvene storitve, d.o.o.

Celje, Slovenia

Internistična Ambulanta Za Pljučne in Alergijske Bolezni - Karmen Kramer Vrščaj Dr. Med.

Celje, Slovenia

MEDICOINTERNA, medicinske storitve in svetovanje, d.o.o.

Kočevje, Slovenia

Zdravstveni Dom Koper Casa Della Sanita Capodistria

Koper, Slovenia

VELOG Zdravstveni center d.o.o.

Kranj, Slovenia

ARJANA MAČEK, zdravstvene in druge storitve, d.o.o

Ljubljana, Slovenia

KAMBIČ - KAFOL, medicinsko svetovanje in storitve, d.o.o.

Ljubljana, Slovenia

MEDI PULMO, interna medicina, d.o.o.

Ljubljana, Slovenia

OBJEM ZDRAVJA zdravstveno svetovalni center d.o.o.

Ljubljana, Slovenia

PULMEDICO, specialistična zdravstvena dejavnost, d.o.o.

Ljubljana, Slovenia

ALVEOLA internistični ambulantni diagnostični center d.o.o.

Maribor, Slovenia

Zasebna Ambulanta Za Pljučne Bolezni, Mag. Alojz Horvat, Dr. Med. Specialist Interne Medicine

Murska Sobota, Slovenia

EUPNEA d.o.o.

Murska Sobota, Slovenia

Zasebna Internistično-Pulmološka Ambulanta, Jasmina Panjan Avramovič, Dr.Med.Spec.

Portorož, Slovenia

DLAN, pomoč in nega na domu, specialistična zdravstvena dejavnost, Lucija Gabršček Parežnik s.p.

Šentjur pri Celju, Slovenia

Zdravstveni Dom Tolmin

Tolmin, Slovenia

Zdravstveni Zavod Pulmoradix Velenje

Velenje, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07489911

Related Trials

Personalized Environment and Genes Study

NCT003412372 locations

Role of Genetic Factors in the Development of Lung Disease

NCT000015322 locations

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

NCT023278971 location

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

NCT06676319229 locations

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT011434801 location